HAP Trading’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-12,400
Closed -$2.15K 1129
2023
Q2
$2.15K Sell
12,400
-800
-6% -$23K ﹤0.01% 995
2023
Q1
$91K Buy
+13,200
New +$377K 0.01% 417
2022
Q4
Sell
-473,400
Closed -$388K 1660
2022
Q3
$388K Buy
+473,400
New +$24.3M 0.03% 409
2021
Q4
Sell
-71,800
Closed -$207K 2651
2021
Q3
$207K Sell
71,800
-2,000
-3% -$238K 0.01% 1019
2021
Q2
$216K Buy
+73,800
New +$9.93M 0.01% 980

Other funds holding GH

HAP Trading's GH Position: Q1 2023 in Review

HAP Trading sold out of Guardant Health (GH) in Q1 2023, closing a stake of 33,438 shares — an estimated $955K sold.

HAP Trading first reported a position in GH in Q4 2022 and held it in 1 quarter. The position peaked at $910K in Q4 2022. 279 funds tracked by Wall St. Rank hold GH as of Q1 2023.

  • HAP Trading reported no remaining Guardant Health position as of Q1 2023 after selling out during the quarter.
  • HAP Trading sold 33,438 Guardant Health shares in Q1 2023, an estimated $955K.
  • HAP Trading first reported a position in Guardant Health in Q4 2022 and held it in 1 quarter.
  • HAP Trading's Guardant Health position peaked at $910K in Q4 2022.
  • 279 funds tracked by Wall St. Rank held Guardant Health as of Q1 2023.

Based on HAP Trading's 13F filing for Q1 2023, filed 12 May 2023.